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Endovascular treatment of intracranial aneurysms as an
alternative to surgical clipping has gained increased
recognition since its introduction in the early 1990s. However,
like all new treatment modalities it has had to prove its
usefulness as an alternative under sceptical scrutiny.  Various
aspects of this form of treatment are still being investigated
and evaluated. One of these is the cost of endovascular
treatment. This is especially pertinent in our setting as a
developing country where one has to ask whether the cost of a
treatment is justified.  With this in mind we looked at the costs
of the treatment incurred in treating posterior communicating
artery (PCom) aneurysms at our hospital over a 1-year period. 
Method
All aneurysm patients admitted to Groote Schuur Hospital
between August 2002 and August 2003 were analysed
retrospectively. As some aneurysms are treated more
successfully with clipping and some with coiling we were
concerned that comparing unmatched groups would introduce
bias. We therefore selected posterior communicating
aneurysms of the carotid artery for cost analysis. In our
opinion PCom aneurysms are equally well treated with either
modality and in our series there was an almost even split in
that of the 17 PCom aneurysms 9 were coiled and 8 were
clipped. Using tariffs for hospital costs based on the National
Price Reference List we proceeded to calculate the costs of
surgical and endovascular treatment. Variables used were time
spent in hospital (to the nearest day), time spent in an intensive
care unit (ICU) (to the nearest hour), time spent in theatre or
the angiogram suite (to the nearest 15 minutes), gases used
during the procedure (to the nearest 15 minutes) and the cost
of surgical or endovascular disposables. Patient folders were
used to determine admission and discharge dates, ICU charts
were used to assess time spent in ICU, and anaesthetic records
were used to assess duration of procedures. With regard to the
disposables used in surgical treatment we used an average
figure for surgically treated patients. In the case of endovas-
cularly treated patients we added up the costs of all the
disposables, specifically catheters and coils (Table I).
The costs were added up and the two groups compared.
Results
Over a 1-year period from August 2002 to August 2003, 58
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The average cost for endovascular treatment per patient was
R37 041. Surgical treatment was more expensive at R44 104,
a difference of 16%.
Conclusions. Despite the high cost of endovascular devices,
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expensive treatment than microsurgical clipping of
aneurysms.
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Table I.  Derivation of costs
Patients coiled Patients clipped
Time spent in hospital Time spent in hospital 
to nearest day to nearest day
Time spent in ICU to Time spent in ICU to 
nearest hour nearest hour
Time spent in angiogram suite Time spent in theatre
Consumables Consumables
Catheters Sutures
Coils Clips
Guidewires Patties
Sheath Plates
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patients with aneurysms were admitted to our institution. Of
these, 17 had PCom aneurysms. Eight patients were treated
surgically and 9 endovascularly. Patient age varied from 36 to
62 years for those treated surgically and from 36 to 79 years for
those treated endovascularly.  Mean ages were 49.1 and 57.6
years and medians 49 and 57.5 years respectively. 
Eight of the 17 patients presented with subarachnoid
haemorrhage (SAH), 4 in each group. Of the patients who
presented with SAH and who were treated surgically 1 had a
WFNS (World Federation of Neurosurgeons) grade I score, 2
were grade II and 1 was grade III. Of those treated
endovascularly 2 were grade I and 2 were grade II. 
The mean cost for patients treated surgically was R44 104,
while the cost of endovascular treatment was R37 041. With
regard to how these figures were reached, the average times
spent in hospital for surgical and endovascular treatment were
441 and 186 hours respectively.  The average times spent in
ICU were 61.8 and 42.2 hours respectively. Patients treated
endovascularly were charged a flat rate for using the
angiogram suite which was equivalent to 2 hours in theatre.
This translates into the surgical option being more expensive
(Table II).
The time taken from admission to procedure was always
shorter for endovascularly treated cases. The median times for
surgical versus endovascular treatment were 18 and 6 days
respectively, with averages of 12 and 5 days respectively (Table II).
Discussion
New and innovative treatment techniques are usually
expensive, especially when the benefits of economy of scale
have not been realised. The International Subarachnoid
Aneurysm Trial (ISAT)1 has done much to establish the
validity of endovascular treatment as an alternative to surgical
clipping and since the early 1990s over 125 000 patients have
been treated successfully using this modality. The ISAT showed
a relative and absolute risk reduction in dependency or death
after allocation to endovascular versus neurosurgical treatment
of 22.6% and 6.9% respectively. The trial was stopped by the
steering committee after 1 year because of the favourable
outcome.  Questioning the appropriateness of perceived
cutting-edge technology in the South African setting is
completely justifiable where costs are an issue. With this in
mind we undertook to establish the exact costs of treating
cerebral aneurysms endovascularly. At Groote Schuur Hospital
we started treating cerebral aneurysms in 2001 and have
treated over 90 patients, establishing the efficacy of this
modality. We hope that we have now also established the cost
effectiveness of endovascular treatment.
It is clear from analysis of the results that endovascular
coiling of aneurysms is not more expensive, and in fact looks to
be more cost effective than surgical clipping. Patients stay in
hospital for a shorter period of time, spend less time in the
ICU, and the procedure is shorter and cheaper. In fact most
patients treated endovascularly do not need to go to an ICU
post procedure but could go to a high care facility. With time
and experience and if the patient is compliant, we are often
finding it more appropriate to do endovascular procedures
under local anaesthetic.
These findings are in keeping with those of Baker et al.2 who
found endovascular patients 40% cheaper to treat than surgical
patients. They also found that patient stay was shorter for
endovascularly treated patients (2 days v. 5 days), and again
this was found to be significant (p < 0.001). 
Time from admission to procedure was considerably less
among the endovascularly treated patients. There are a number
of reasons for this, including difficulty at our institution in
getting a timely angiogram because of limited resources and
the number of trauma cases that occupy the angiography suite
and personnel time. Secondly, we often proceed straight from
the diagnostic angiogram to the endovascular coiling. Theatre
time is also at a premium, again because of trauma. Other
institutions may not experience these problems and one can
argue that the delay in admission to procedure time accounts
for a large proportion of the increased cost in the surgically
treated group. However, the reality is that within our setting
the problems we describe are real and difficult to overcome. We
have found that being able to treat aneurysms endovascularly
and especially under local anaesthetic has paradoxically freed
up theatre time, allowing other surgical procedures to be done.
Table II illustrates that the procedure time was much shorter
Table II.  Summary of results 
Clipped Coiled Clipped Clipped Coiled Coiled
(average) (average) (max) (min) (max) (min)
Hours spent in hospital 441 186 168 1 035 48 437
Hours in ICU 61.8 42.4 20 115 17 113
Time (h) for procedure 3.5 1.5 3.5 5.25 1.5 2.25
Time (d) from admission 
to procedure 12 4.8 3 36 1 11
Cost in rands 44 104 37 041 78 929 30 753 61 395 23 288
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for patients treated endovascularly. We pay a fixed rate for the
angiogram suite which is the equivalent of 2 hours in theatre.
At no time was an operative procedure cheaper to perform
than the endovascular procedure and for 7 of the 9 patients
treated endovascularly we were charged for time we did not
require. Patients with PCA aneurysms often present with third
nerve palsies or retro-orbital pain and then do not experience
the morbidity and mortality associated with SAH. In both
groups the patients who accounted for a long stay in hospital
had SAHs. While it is possible to expedite the treatment and
prevent re-bleeding using endovascular techniques, the SAH
and its complications remain.
In conclusion, while endovascular treatment of cerebral
aneurysms is new and perceived as cutting-edge treatment, we
have been able to show that within our health care system its
utilisation is cost effective and justifiable. Other advantages
with regard to cost include minimal infection risk, potential to
perform treatments under local anaesthetic and, with time, a
reduction in the cost of disposables as a result of economy of
scales. These factors will further help reduce the cost of this
new and effective treatment.
No direct funding or sponsorship was received for this
study. Both authors was attended sponsored educational
meetings and workshops paid for by suppliers of surgical
aneurysm clips and endovascular coils. However, the majority
of educational funding was received from the Taeuber
Management Trust.
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Additions to the list of cardiac risk factors
IN BRIEF
A news item in the BMJ (2004; 329: 527) gives a list of nine risk factors which explain most heart attacks: an abnormal ratio
of apolipoprotein A to apolipoprotein B — a more sensitive marker than the ratio of high- to low-density lipoprotein;
smoking; high blood pressure; diabetes; abdominal obesity; low daily fruit and vegetable consumption; a lack of exercise; and
stress. These findings were presented at the European Society of Cardiology congress in Munich in October. Adding to
these, an article in the Quarterly Journal of Medicine (204; 97: 637-643) examines the effect of traffic air pollution during
exercise, and suggests that exposure to air-borne toxins should be minimised. The exhaust from fuel combustion contains a
diverse mixture of suspended particles and gases containing reactive free radical species. Recent epidemiological studies have
confirmed earlier suspicions that there is a consistent association between ambient concentrations of particulate matter and
cardiovascular morbidity. Exercising individuals exposed to automotive air pollution may be at heightened risk because, even
at low intensities, a significant rise in pulmonary ventilation and diffusion capacity occurs, increasing the amount of inspired
particles. Adding 'fuel to the fire' is an article in the New England Journal of Medicine (2004; 351: 1721-1730) concluding that
transient exposure to traffic may increase the risk of myocardial infarction in susceptible persons.The subjects' use of a car
was the most common source of exposure to traffic, but time spent on public transportation also showed an association.
